Fund Holdings — Kynam Capital Management, LP

Total Portfolio Value:
$1.81B
Total Bought:
$384.83M
Total Sold:
$217.98M
Net Transaction:
+$166.84M
Notable People:
Kynam Capital Management Gp,
Securities
▲▼
SharesValue
Q1 2026
▲▼
Q2 2026
▲▼
Change
▲▼
Q1 2026
▲▼
Q2 2026
▲▼
Weight (%)
▲▼
Change
▲▼
Celldex Therapeutics, Inc.(CLDX)5,840,5675,322,908-517,659$185.26M$198.07M10.95%+$12.80M
Syndax Pharmaceuticals, Inc.(SNDX)8,050,9598,050,9590$188.07M$175.99M9.73%-$12.08M
Vaxcyte, Inc.(PCVX)2,922,3352,922,3350$169.82M$169.88M9.39%+$58.4K
Cogent Biosciences, Inc.(COGT)4,037,3313,667,097-370,234$155.40M$141.92M7.84%-$13.48M
Vera Therapeutics, Inc.CL A(VERA)3,398,2242,890,059-508,165$136.71M$124.01M6.85%-$12.70M
Viridian Therapeutics, Inc.(VRDN)2,341,6526,453,877+4,112,225$45.80M$118.56M6.55%+$72.76M
Travere Therapeutics, Inc.(TVTX)1,569,0182,000,000+430,982$46.62M$113.62M6.28%+$67.00M
Beam Therapeutics Inc.(BEAM)3,682,1852,840,792-841,393$87.75M$97.50M5.39%+$9.75M
UroGen Pharma Ltd.(URGN)2,247,3932,434,207+186,814$40.41M$89.58M4.95%+$49.17M
Legend Biotech CorporationADS(LEGN)1,576,2953,001,205+1,424,910$28.52M$86.67M4.79%+$58.16M
CytomX Therapeutics, Inc.(CTMX)15,013,09321,703,093+6,690,000$70.56M$81.39M4.50%+$10.83M
Relay Therapeutics, Inc.(RLAY)1,424,2593,300,000+1,875,741$14.17M$61.74M3.41%+$47.57M
Cullinan Therapeutics, Inc.(CGEM)3,114,1323,114,1320$44.25M$56.71M3.13%+$12.46M
MBX Biosciences, Inc.(MBX)934,799934,7990$27.90M$51.60M2.85%+$23.70M
Immunocore Holdings plcADS(IMCR)884,9371,375,000+490,063$26.68M$43.66M2.41%+$16.98M
Nurix Therapeutics, Inc.(NRIX)1,194,7571,194,7570$18.52M$28.98M1.60%+$10.47M
Sutro Biopharma, Inc.(STRO)872,558872,5580$21.74M$28.97M1.60%+$7.23M
BioCryst Pharmaceuticals, Inc.(BCRX)5,680,7952,522,660-3,158,135$54.08M$25.23M1.39%-$28.85M
Pharvaris N V
COM
640,395661,795+21,400$18.09M$22.88M1.26%+$4.79M
Summit Therapeutics Inc.(SMMT)01,200,000+1,200,000$0$17.48M0.97%+$17.48M
Prelude Therapeutics Incorporated(PRLD)1,592,5512,415,087+822,536$5.45M$12.87M0.71%+$7.43M
Insmed Incorporated(INSM)0100,000+100,000$0$10.66M0.59%+$10.66M
Burning Rock Biotech LimitedADS(BNR)1,227,5551,238,563+11,008$19.79M$10.52M0.58%-$9.27M
Geron Corporation(GERN)6,836,3186,836,3180$10.19M$8.75M0.48%-$1.44M
Amarin Corp PlcADR472,382532,982+60,600$6.83M$8.50M0.47%+$1.67M
Alector Inc2,000,0003,808,494+1,808,494$4.30M$7.66M0.42%+$3.36M
Parabilis Medicines Inc0250,000+250,000$0$6.84M0.38%+$6.84M
Caribou Biosciences, Inc.(CRBU)2,503,3022,503,3020$4.76M$4.41M0.24%-$350.5K
Proqr Thrapeutics N VSHS EURO
SHS EURO
1,566,3171,566,3170$2.54M$2.91M0.16%+$375.9K
Candel Therapeutics, Inc.(CADL)200,00096,741-103,259$980.0K$996.4K0.06%+$16.4K
enGene Therapeutics Inc.(ENGN)0457,855+457,855$0$792.1K0.04%+$792.1K
Traws Pharma, Inc.(TRAW)084,400+84,400$0$71.2K0.00%+$71.2K
Apellis Pharmaceuticals Inc
COM
825,0000-825,000$33.19M$0—-$33.19M
Biohaven Ltd.(BHVN)702,8840-702,884$5.95M$0—-$5.95M
Climb Bio, Inc.(CLYM)1,003,3410-1,003,341$6.87M$0—-$6.87M
Design Therapeutics, Inc.(DSGN)784,6060-784,606$8.35M$0—-$8.35M
Engene Holdings Inc
COM
1,356,8430-1,356,843$9.24M$0—-$9.24M
Evommune, Inc.(EVMN)625,4960-625,496$14.38M$0—-$14.38M
Kalvista Pharmaceuticals Inc1,820,9540-1,820,954$36.66M$0—-$36.66M
Soleno Therapeutics Inc560,0000-560,000$18.75M$0—-$18.75M
Wave Life Sciences, Inc.SHS(WVE)965,1930-965,193$7.00M$0—-$7.00M
Page 1 of 1
Kynam Capital Management, LP — 13F Holdings — Q2 2026 | TickerTrail